Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-22-025941
Filing Date
2022-05-12
Accepted
2022-05-12 16:06:50
Documents
18
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2021a1_pasitheathera.htm   iXBRL 10-K/A 182577
2 EXECUTIVE EMPLOYMENT AGREEMENT, DATED AS OF JANUARY 1, 2022, BETWEEN PASITHEA TH f10k2021a1ex10-15_pasithea.htm EX-10.15 86650
3 STOCK OPTION AGREEMENT, DATED DECEMBER 20, 2021, BETWEEN PASITHEA THERAPEUTICS C f10k2021a1ex10-16_pasithea.htm EX-10.16 37494
4 RESTRICTED STOCK UNIT AGREEMENT, DATED DECEMBER 20, 2021, BETWEEN PASITHEA THERA f10k2021a1ex10-17_pasithea.htm EX-10.17 69248
5 CERTIFICATION f10k2021a1ex31-3_pasithea.htm EX-31.3 7233
6 CERTIFICATION f10k2021a1ex31-4_pasithea.htm EX-31.4 7453
  Complete submission text file 0001213900-22-025941.txt   698890

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ktta-20211231.xsd EX-101.SCH 3273
8 XBRL DEFINITION FILE ktta-20211231_def.xml EX-101.DEF 16943
9 XBRL LABEL FILE ktta-20211231_lab.xml EX-101.LAB 36304
10 XBRL PRESENTATION FILE ktta-20211231_pre.xml EX-101.PRE 18002
12 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021a1_pasitheathera_htm.xml XML 6771
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40804 | Film No.: 22917790
SIC: 2834 Pharmaceutical Preparations